HBM BioVentures

Financial reports for the 2009/2010 financial year
(1 April 2009 to 31 March 2010)

News

Press Releases
»	HBM BioVentures Quarterly Report as at 30 June 2010
»	HBM BioVentures’ largest public investment – Micrus – acquired by Johnson & Johnson
»	HBM BioVentures sells USD hedging position at a profit
»	Shareholders’ meeting approves all proposals by Board of Directors by large majority; Hans Peter Hasler appointed as new Chairman of the Board of Directors; Astellas, which recently acquired OSI Pharmaceuticals, will retain HBM BioVentures shares and intensify cooperation
»	Archive

Financial Reports

Share Price

SIX Swiss Exchange Ticker
HBMN

Key Figures

News Registration